Search

Susan Hoiseth

from Suffern, NY
Get Report
Also known as:
Susan Hoiseth Love, Susan K Hoiseth
Connected to:
Turi I Hoiseth, 45Andrea D Hoisington, 71Ben P Hoisington, 72Brandi N Hoisington, 48Cheryl A Hoisington, 70Cindy L Hoisington, 63David A Hoisington, 71Kevin S Hoisington, 57Laura S Hoisington, 62Lenus Hoisington, 36

Susan Hoiseth Phones & Addresses

  • Suffern, NY
  • Foley, MN
  • Nanuet, NY
  • Fort Bragg, NC
  • Fairport, NY
  • Princeton, MN
  • Saline, MI
  • Milan, MI

Publications

Us Patents

Formulations Of Hydrophobic Proteins In An Immunogenic Composition Having Improved Tolerability

View page
US Patent:
7608278, Oct 27, 2009
Filed:
Dec 28, 2004
Appl. No.:
10/585050
Inventors:
Susan Kay Hoiseth - Montebello NY, US
Yury Vladimirovich Matsuka - New Windsor NY, US
Michael Hagen - Pittsford NY, US
Lakshmi Khandke - Nanuet NY, US
Assignee:
Wyeth - Madison NJ
International Classification:
A61K 45/00
A61K 47/00
A61K 49/00
US Classification:
4242781, 424 91, 424 92
Abstract:
The present invention provides a method for producing a less-painful immunogenic composition of a hydrophobic protein in a pharmaceutically acceptable carrier suitable for administering to a mammal, comprising the steps of (a) solubilizing said hydrophobic protein with a zwitterionic detergent to make a first composition; (b) altering said first composition, such that the altered composition produces a reduction in pain as measured in the rat footpad model as compared to said first composition.

Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens

View page
US Patent:
20120093852, Apr 19, 2012
Filed:
Nov 11, 2011
Appl. No.:
13/295030
Inventors:
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
Kathrin Ute Jansen - Allendale NJ, US
Mark E. Ruppen - Garnerville NY, US
Justin Keith Moran - Valley Cottage NY, US
Susan Kay Hoiseth - Montebello NY, US
Assignee:
Wyeth LLC - Madison NJ
International Classification:
A61K 39/095
A61P 37/04
C07K 14/22
US Classification:
4241901, 530350
Abstract:
The present invention relates to compositions including an isolated non-pyruvylated non-lipidated ORF2086 polypeptide, and methods thereof. In an exemplary embodiment, the compositions described herein are immunogenic. The present invention further relates to compositions that elicit a bactericidal immune response in a mammal against an ORF2086 subfamily B polypeptide from serogroup B , and methods related thereto.

Neisseria Meningitidis Compositions And Methods Thereof

View page
US Patent:
20130243807, Sep 19, 2013
Filed:
Mar 6, 2013
Appl. No.:
13/787594
Inventors:
Susan Kay Hoiseth - Montebello NY, US
Kathrin Ute Jansen - Allendale NJ, US
Justin Keith Moran - Valley Cottage NY, US
Mark E. Ruppen - Garnerville NY, US
Assignee:
PFIZER INC. - New York NY
International Classification:
A61K 39/095
C07K 14/22
US Classification:
4241901, 530350, 536 237
Abstract:
In one aspect, the invention relates to an isolated polypeptide comprising an amino acid sequence that is at least 95% identical to SEQ ID NO: 71. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.

Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens

View page
US Patent:
20200093914, Mar 26, 2020
Filed:
Oct 10, 2019
Appl. No.:
16/598661
Inventors:
- New York NY, US
Kathrin Ute Jansen - New York NY, US
Mark Edward Ruppen - Cresco PA, US
Justin Keith Moran - West Nyack NY, US
Susan Kay Hoiseth - Tampa FL, US
International Classification:
A61K 39/095
C07K 14/22
Abstract:
The present invention relates to compositions including an isolated non-pyruvylated non-lipidated ORF2086 polypeptide, and methods thereof. In an exemplary embodiment, the compositions described herein are immunogenic. The present invention further relates to compositions that elicit a bactericidal immune response in a mammal against an ORF2086 subfamily B polypeptide, from serogroup B and methods related thereto.

Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens

View page
US Patent:
20170326222, Nov 16, 2017
Filed:
May 5, 2017
Appl. No.:
15/587574
Inventors:
- New York NY, US
Kathrin Ute Jansen - New York NY, US
Mark Edward Ruppen - Garnerville NY, US
Justin Keith Moran - West Nyack NY, US
Susan Kay Hoiseth - Tampa FL, US
International Classification:
A61K 39/095
C07K 14/22
A61K 39/00
A61K 39/00
Abstract:
The present invention relates to compositions including an isolated non-pyruvylated non-lipidated ORF2086 polypeptide, and methods thereof. In an exemplary embodiment, the compositions described herein are immunogenic. The present invention further relates to compositions that elicit a bactericidal immune response in a mammal against an ORF2086 subfamily B polypeptide from serogroup B , and methods related thereto.

Neisseria Meningitidis Compositions And Methods Thereof

View page
US Patent:
20160030543, Feb 4, 2016
Filed:
Jan 23, 2015
Appl. No.:
14/604620
Inventors:
- New York NY, US
Susan Kay Hoiseth - Montebello NY, US
Kathrin Ute Jansen - Allendale NJ, US
Justin Keith Moran - Valley Cottage NY, US
Mark E. Ruppen - Garnerville NY, US
Annaliesa Sybil Anderson - Upper Saddle River NJ, US
John Erwin Farley - Chapel Hill NC, US
Liesel A. Bernfield - Rochester NY, US
International Classification:
A61K 39/095
C07K 14/22
Abstract:
In one aspect, the invention relates to an isolated polypeptide comprising an amino acid sequence that is at least 95% identical to SEQ ID NO: 71. In another aspect, the invention relates to an immunogenic composition including an isolated non-lipidated, non-pyruvylated ORF2086 polypeptide from serogroup B, and at least one conjugated capsular saccharide from a meningococcal serogroup.
Control profile
Susan Hoiseth from Suffern, NY Get Report